Monoclonal gammopathy of undetermined significance, multiple myeloma, and osteoporosis

Joint, Bone, Spine : Revue Du Rhumatisme
Béatrice BouvardErick Legrand

Abstract

The finding of monoclonal gammopathy of undetermined significance (MGUS) is not infrequent during an evaluation for osteoporosis or a fracture. In most cases, the diagnosis is MGUS, whose prevalence increases with age. Although the impact of MGUS on bone mineral density, bone remodeling, and the fracture risk remains unclear, this asymptomatic hematological disorder may constitute a risk factor for osteoporosis. Furthermore, each year, 1% of patients with MGUS progress to multiple myeloma, a disease whose pathophysiology and association with bone loss and pathological fractures are increasingly well understood. Osteoporotic fractures, although probably common in myeloma patients, are less likely to be recognized. Here, we discuss the pathophysiology of myeloma and MGUS and their impact in terms of bone mineral density, osteoporotic fractures, and bone turnover markers.

References

Dec 1, 1992·The American Journal of Medicine·X MarietteJ P Fermand
Feb 22, 2002·The New England Journal of Medicine·Robert A KyleL Joseph Melton
Nov 9, 2002·Blood·Orhan SezerLorenz Christian Hofbauer
Jul 8, 2003·International Journal of Cancer. Journal International Du Cancer·Evangelos TerposAmin Rahemtulla
Aug 14, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Pellegrino MustoAngelo Michele Carella
Dec 26, 2003·The New England Journal of Medicine·Erming TianJohn D Shaughnessy
Mar 8, 2005·Blood Reviews·Evangelos TerposAmin Rahemtulla
Jun 2, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E Terpos, M-A Dimopoulos
Jan 27, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Inge TinhoferRichard Greil
Mar 31, 2006·The New England Journal of Medicine·Robert A KyleL Joseph Melton
Aug 19, 2006·Blood·Nicola GiulianiG David Roodman
Sep 20, 2006·Experimental Hematology·Rohit AggarwalG David Roodman
Jun 22, 2007·The New England Journal of Medicine·Robert A KyleS Vincent Rajkumar
Nov 13, 2007·Hematology/oncology Clinics of North America·Robert A Kyle, S Vincent Rajkumar
Jan 9, 2008·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·B J EdwardsM Favus
Aug 7, 2008·Cancer·Pellegrino MustoUNKNOWN GIMEMA (Italian Group for Adult Hematologic Diseases)/Multiple Myeloma Working Party and the Italian Myeloma Network
Oct 3, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·James R BerensonRegina A Swift

❮ Previous
Next ❯

Citations

Jan 10, 2012·Cancer Treatment Reviews·Maurizio ZangariGuido Tricot
Mar 5, 2011·Critical Reviews in Oncology/hematology·Evangelos TerposJames Berenson
Oct 14, 2011·European Journal of Haematology·Paul G RichardsonKenneth C Anderson
Jul 19, 2013·European Journal of Haematology·Silvia MangiacavalliAlessandro Corso
Apr 1, 2015·Nature Communications·Takako Negishi-KogaHiroshi Takayanagi
Feb 9, 2019·Expert Review of Endocrinology & Metabolism·Luciano ColangeloSalvatore Minisola
Nov 30, 2018·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·E M SteinE Shane
Apr 12, 2021·European Journal of Haematology·Saemundur RögnvaldssonSigurður Yngvi Kristinsson
Aug 14, 2021·Journal of Dental Research, Dental Clinics, Dental Prospects·Juliano Milanezi de AlmeidaDavid Jonathan Rodrigues Gusman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.